Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)NCT02606136Kyntra BioPhase 2Terminated2020-05-07Actual
Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic LeukemiaNCT02612311TGTXPhase 3Terminated2023-02-22Actual
A Study to Evaluate SAGE-547 in Participants With Severe Postpartum DepressionNCT02614547SUPNPhase 2Completed2016-06-22Actual
Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)NCT02618408SUPNPhase 3Completed2019-09-04Actual
Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)NCT02618434SUPNPhase 3Completed2019-11-15Actual
A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal ImmunizationNCT02624947NovavaxPhase 3Completed2018-12-28Actual
Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for HemodialysisNCT02644941HUMAPhase 3Completed2019-05Actual
Tradipitant in Treatment-resistant Pruritus Associated With Atopic DermatitisNCT02651714Vanda PharmaceuticalsPhase 2Completed2017-08-04Actual
A Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With Umbralisib for Participants Previously Enrolled in Protocol UTX-TGR-304NCT02656303TGTXPhase 2Terminated2022-05-26Actual
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid LeukemiaNCT02665065Actinium PharmaceuticalsPhase 3Active not recruiting2022-06Actual
Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular MelanomaNCT02678572DCTHPhase 3Completed2023-05-18Actual
Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721NCT02682407Omeros CorporationPhase 2Terminated2020-08-25Actual
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionNCT02682511Cumberland PharmaceuticalsPhase 2Active not recruiting2026-03Actual
Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4)NCT02691182SUPNPhase 3Terminated2021-05Actual
Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and CisplatinNCT02709512Polaris GroupPhase 2, Phase 3Completed2022-08-15Actual
Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSHNCT02716246RAREPhase 2, Phase 3Recruiting2029-03Estimated
ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor TreatmentNCT02735863ABVXPhase 2Completed2017-08-30Actual
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)NCT02736656SUPNPhase 3Active not recruiting2026-09Estimated
A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell TransplantationNCT02737306CytoDyn, Inc.Phase 2Terminated2021-04-14Actual
Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) InfectionNCT02738008Arrowhead PharmaceuticalsPhase 2Terminated2016-12Actual
Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior TherapyNCT02742090TGTXPhase 2Terminated2021-06-10Actual
Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic SolutionNCT02754596Glaukos CorporationPhase 2Completed2017-08-01Actual
Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)NCT02768363CADLPhase 2Active not recruiting2024-11Actual
Tipifarnib in Subjects With Myelodysplastic SyndromesNCT02779777KURAPhase 2Terminated2018-08-28Actual
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AMLNCT02781883Bio-Path Holdings, Inc.Phase 2Recruiting2027-12Estimated
Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid LeukemiaNCT02807272KURAPhase 2Completed2020-11-30Actual
Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer PatientsNCT02826486BLRXPhase 2Completed2022-09-06Actual
Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With FibromyalgiaNCT02829814Tonix Pharmaceuticals, Inc.Phase 3Terminated2016-09-13Actual
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).NCT02831959NovoCure GmbHPhase 3Completed2024-11-29Actual
A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel ResectionNCT02836470Palisade BioPhase 2Completed2023-09-06Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.